Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Vaccines
Filter     Order     Display # 
Date Item Title
26 Jan 2007 FDA Advisory Committee Recommends Licensure Of New Pediatric Combination Vaccine
24 Jan 2007 Commencement of Pollinex(R) Quattro Grass Dosing.
23 Jan 2007 Cell Genesys Announces Encouraging Follow-Up Survival Data From Phase 2 Clinical Trial of GVAX(R) Immunotherapy for Pancreatic Cancer
20 Jan 2007 BioMS Medical Cleared By FDA To Initiate Pivotal Phase III Multiple Sclerosis Trial
19 Jan 2007 GlaxoSmithKline initiates head-to-head study of cervical cancer vaccines
18 Jan 2007 First Malaria Vaccine Trial Launched Under GenVec/U.S. Navy Collaboration
18 Jan 2007 Acambis receives Complete Response Letter from FDA on ACAM2000 Biologics Licence Application
17 Jan 2007 Novavax and Collaborators Significantly Improve VLP Vaccine for HIV/AIDS
17 Jan 2007 Dendreon's PROVENGE Granted FDA Priority Review for the Treatment of Asymptomatic, Metastatic, Androgen-Independent Prostate Cancer
12 Jan 2007 Curalogic has started clinical phase II trial with its grass product
09 Jan 2007 Dynavax Reports Interim TOLAMBA(TM) Ragweed Allergy Results From DARTT Trial
09 Jan 2007 FDA Approves MedImmune's Refrigerated Formulation of FluMist(R)
05 Jan 2007 Vical Initiates Pivotal Phase 3 Trial of Allovectin-7(R) as First-line Therapy for Metastatic Melanoma
04 Jan 2007 Bavarian Nordic A/S receives approval to start Phase I/II trials with breast cancer vaccine
03 Jan 2007 Stimuvax(R) Phase III clinical trial in patients with non-small cell lung cancer now open for patient enrollment
21 Dec 2006 Dynavax Initiates Pivotal Phase 3 Trial for HEPLISAV(TM), Hepatitis B Vaccine
20 Dec 2006 Prophylactic Staphylococcus aureus subunit vaccine shows promising results
16 Dec 2006 GlaxoSmithKline reaches EU regulatory milestone in its flu pandemic vaccine development programme
15 Dec 2006 Positive Phase II Clinical Trial Results with HER2/neu Vaccine
13 Dec 2006 Intercell's therapeutic Hepatitis C vaccine safe in combination with standard therapy
13 Dec 2006 Phase II trial of GV1001 in lung cancer started
13 Dec 2006 Biomira receives special protocol assessment from the FDA for Phase III trial of Stimuvax for non-small cell lung cancer
12 Dec 2006 Merck & Co., Inc. and Idera Pharmaceuticals Sign Collaboration Agreement Incorporating Idera’s Toll-like Receptor Agonists in Merck’s Vaccine Programs
09 Dec 2006 Oxford Biomedica’s Trovax Receives Positive Recommendation For Orphan Drug Designation In Renal Cancer From EMEA
07 Dec 2006 Japanese Study Confirms Safety And Efficacy Of Intravenous Rexin-G™ As Treatment For Diverse Metastatic Cancers
05 Dec 2006 Inovio Biomedical Partner Tripep Files Application for Phase I Clinical Study of Hepatitis C DNA Vaccine
05 Dec 2006 Dynavax's HEPLISAV(TM) Hepatitis B Vaccine Shows 100% Seroprotection Regardless of Vaccination Schedule in Phase 2 Trial
30 Nov 2006 AVAX Technologies Launches Global Phase III Registration Clinical Trial of M-Vax in Metastatic Melanoma
29 Nov 2006 Dynavax's HEPLISAV(TM) Hepatitis B Vaccine Shows Statistically Significant Results in Phase 3 Trial
29 Nov 2006 Northwest Biotherapeutics Receives Institutional Review Board Approval to Accrue Patients In Phase II Brain Cancer Trial
28 Nov 2006 Pharmexa has started phase II trial in liver cancer with GV1001
28 Nov 2006 MannKind Corporation Announces Clearance of IND for MKC1106-PP Immunotherapy in Solid Malignancies
24 Nov 2006 BioMS Medical commences enrolment in a relapsing remitting multiple sclerosis trial
23 Nov 2006 Nventa Provides Clinical Development Strategy Update On Lead Program HSPE7
18 Nov 2006 Virax gets green light for commencement of Phase II US clinical trials of VIR201
14 Nov 2006 Favrille Announces Interim Analysis of Secondary Endpoint from Pivotal Phase 3 Clinical Trial of FavId Following Rituxan in Follicular B-Cell Non-Hodgkin's Lymphoma
13 Nov 2006 Dynavax Reports New TOLAMBA Data at ACAAI Meeting
10 Nov 2006 SIGA Passes Another Milestone with Smallpox Drug SIGA-246
10 Nov 2006 Oxford Biomedica Reports Further Encouraging Phase Ii Results With Trovax In Renal And Prostate Cancer
10 Nov 2006 MedImmune Files Investigational New Drug Application for Cell Culture-Based Influenza Vaccine
09 Nov 2006 Novavax's Pandemic Influenza Vaccine Candidates Trigger Robust Immune Response In Pre-Clinical Models
08 Nov 2006 SciGen Announces Marketing Approval of Hepaptitis Vaccine in India
08 Nov 2006 Phase I/IIa clinical trial with obese individuals shows no effect
08 Nov 2006 Inovio Biomedical Grants Wyeth Pharmaceuticals License to Develop Infectious Disease DNA Vaccines
08 Nov 2006 Oxford Biomedica Commences Phase III Trial Of Trovax (R) In Renal Cancer
07 Nov 2006 Generex Biotechnology to Begin the First Human Clinical Trial of Avian Influenza Vaccine
07 Nov 2006 Opexa Begins Dosing Patients in Phase IIb Trial of Tovaxin (TM) for Multiple Sclerosis
04 Nov 2006 Next Clinical Trial of VaxGen's Anthrax Vaccine Delayed
26 Oct 2006 Crucell and AERAS Announce Start of Tuberculosis Vaccine Clinical Trial
21 Oct 2006 Single Injection of Vical's Avian Flu DNA Vaccine Provides 100% Protection in Ferrets
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 351 - 400 of 599

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Emerging Diabetes Drugs

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics